Insider Stock Trading History of Cooper Graham K


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Cooper Graham K since year 2005. The trader's CIK number is 1396943. At the time of this reporting, Cooper Graham K is the Chief Financial Officer of Receptos, Inc. . (stock ticker symbol RCPT). See this page for all insider trading activities at Receptos, Inc. .

Note that in the past COOPER GRAHAM K also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Cooper Graham K since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-09-16 RCPT Receptos, Inc. Option Ex 50,000 5.10 254,999
2014-09-16 RCPT Receptos, Inc. Sale 50,000 61.30 3,065,000
2009-12-21 OREX Orexigen Therapeutics, Inc. Option Ex 100,000 .70 70,000
2009-12-21 OREX Orexigen Therapeutics, Inc. Sale 82,500 8.25 680,460
2009-12-21 OREX Orexigen Therapeutics, Inc. Sale 17,500 8.41 147,157
2008-08-21 OREX Orexigen Therapeutics, Inc. Option Ex 8,259 .70 5,781
2008-08-21 OREX Orexigen Therapeutics, Inc. Sale 8,259 12.00 99,108
2007-12-20 OREX Orexigen Therapeutics, Inc. Option Ex 4,000 .70 2,800
2007-12-20 OREX Orexigen Therapeutics, Inc. Sale 4,000 14.10 56,400
2007-11-20 OREX Orexigen Therapeutics, Inc. Sale 4,000 14.75 58,984
2007-11-20 OREX Orexigen Therapeutics, Inc. Option Ex 4,000 .70 2,800

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cooper Graham K (Chief Financial Officer of Receptos, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.